Can Silver Diamine Fluoride Stop Cavities Without Drilling?
For decades, treating a cavity meant the familiar sequence of anesthesia, drilling away decayed tooth structure, and placing a filling. That process remains the standard for many cases, yet a simple liquid treatment has steadily gained ground as a non-invasive alternative that can halt the progression of tooth decay without removing any healthy tissue. Silver diamine fluoride, commonly called SDF, is applied with a tiny brush in seconds. Growing clinical evidence shows it can stop many cavities in their tracks, offering a painless option especially valuable for young children, older adults, and patients who struggle with traditional dental care.
SDF is a clear or lightly tinted liquid containing silver, fluoride, ammonia, and water, typically formulated at a 38 percent concentration. The silver component acts as a potent antimicrobial agent. When painted onto an active cavity, silver ions penetrate the softened, demineralized tooth structure, kill cavity-causing bacteria, disrupt biofilms, denature bacterial proteins, and inhibit the enzymes that break down collagen in dentin. At the same time, the high concentration of fluoride promotes remineralization. It helps convert the softened tissue into a harder, more acid-resistant form by encouraging the formation of fluorapatite. The ammonia keeps the solution stable and alkaline, creating an environment less favorable to acid-producing bacteria. The combined effect is that an active lesion often hardens and stops progressing. One visible consequence is permanent dark staining of the treated decay, caused by silver compounds reacting with proteins in the damaged tissue. Healthy enamel is usually far less affected.
The treatment itself is remarkably straightforward. A dentist or hygienist cleans and dries the area, applies the liquid with a microbrush or sponge-tipped applicator for a few seconds per tooth, and blots away excess. No local anesthetic is required, no drill is used, and the appointment can last only a few minutes even when several teeth are treated. Patients can typically resume normal eating and activities immediately afterward. Because the procedure is so brief and painless, it is particularly useful for toddlers, children with severe early childhood caries, individuals with developmental or physical disabilities, people with intense dental anxiety, and older adults with root caries or limited mobility.
A major Phase III randomized clinical trial published in 2026 in JAMA Pediatrics has strengthened the evidence base for SDF in young children. Researchers led by the University of Michigan enrolled 830 children under age six who had severe early childhood caries. Participants were recruited from dental offices, pediatric medical practices, and Head Start programs across Michigan, New York, and Iowa. The study compared 38 percent SDF applied at six-month intervals against a placebo. At the primary six-month endpoint, SDF arrested 54 percent of treated dentin lesions, more than twice the 22.5 percent arrest rate seen with placebo. Differences remained significant at three months and eight months. Pain levels and overall adverse events were similar between the two groups. Most side effects were mild to moderate, and treatment-related events occurred at comparable rates. Lead investigator Margherita Fontana noted that the treatment is effective and safe even in children as young as one year old. The trial supplies the kind of rigorous U.S. data that can support broader regulatory recognition and insurance coverage for caries arrest.
Earlier research and systematic reviews had already pointed in the same direction. Multiple studies report arrest rates commonly ranging from 65 to 90 percent with repeated applications, particularly for primary teeth and for root surface caries in older adults. A Cochrane review found that SDF may help arrest caries in the primary dentition and is likely to prevent new root caries, although the certainty of evidence varies depending on the specific outcome and tooth type. School-based programs have also demonstrated that a single application of SDF can prevent a large proportion of new cavities and stop the progression of existing ones at rates comparable to traditional sealants. In practical terms, SDF has been used for decades in countries such as Japan, Australia, and Brazil. In the United States it received FDA clearance in 2014 as a Class II medical device for treating dentinal hypersensitivity. Its use to arrest caries has long been an accepted off-label application, supported by guidelines from the American Academy of Pediatric Dentistry and the American Academy of Pediatrics. The recent large trial is expected to facilitate formal drug approval for caries management, which could expand access, improve product consistency, and increase reimbursement.
The advantages extend beyond the absence of drilling. SDF is inexpensive compared with restorative treatment, requires minimal equipment and training, and can stabilize disease quickly. For a young child who might otherwise need general anesthesia in an operating room to manage multiple cavities, SDF can interrupt the cycle of pain, infection, difficulty eating, and disrupted sleep. In some cases, repeated applications every six months may be sufficient to manage lesions on baby teeth until those teeth naturally exfoliate. For adults, SDF can serve as a long-term management strategy for root caries or as a temporary bridge until conventional restoration becomes feasible. It also reduces sensitivity in treated areas. Because it kills bacteria rather than simply covering them, it addresses the infectious nature of caries in a way that traditional fillings alone do not.
SDF is not a universal solution. It does not restore the original shape or structural integrity of a tooth. A cavitated lesion remains a physical hole even after the decay is arrested, so large lesions, those in high-load areas, or teeth that require precise contour for chewing or aesthetics may still need conventional fillings, crowns, or other restorative work later. The permanent black staining of treated decay is the most commonly cited drawback. While often acceptable on posterior teeth or primary teeth that will eventually be lost, it can be cosmetically undesirable on visible anterior surfaces. Reapplication is usually necessary for sustained benefit; a single treatment is frequently insufficient over the long term. SDF is contraindicated in patients with a known silver allergy. Mild and temporary effects such as a metallic taste or minor soft-tissue irritation can occur, but serious systemic adverse events are rare when the material is used according to professional guidelines.
Proper case selection and ongoing monitoring remain essential. A dentist evaluates the activity, size, and location of lesions, the patient’s overall risk factors, and the feasibility of maintaining good oral hygiene and diet. SDF works best as part of a comprehensive approach that includes fluoride toothpaste, reduced sugar exposure, regular professional care, and, when appropriate, other preventive measures such as sealants. It does not replace the need for routine dental examinations to confirm that arrested lesions remain stable.
In short, silver diamine fluoride offers a scientifically supported, low-cost, and minimally invasive way to stop many cavities from progressing without the drill. Recent high-quality trial data reinforce what clinicians in many parts of the world have observed for years: painting a simple liquid onto decay can harden the tissue, kill bacteria, and spare patients—especially the most vulnerable—considerable discomfort and complexity. While it will not eliminate the need for traditional restorative dentistry in every situation, SDF has already expanded the toolkit available to dentists and improved access to care for patients who previously had few comfortable options. As regulatory pathways clear and clinical experience continues to grow, this once-specialty treatment is poised to become a more routine part of everyday caries management.
About The Author
